TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biotrans i Nord AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
939
|
1,345
|
1,498 |
Financial expenses |
26
|
14
|
9 |
Earnings before taxes |
-183
|
-48
|
0 |
EBITDA |
-11
|
100
|
136 |
Total assets |
1,652
|
1,205
|
1,099 |
Current assets |
407
|
202
|
215 |
Current liabilities |
458
|
416
|
373 |
Equity capital |
59
|
66
|
113 |
- share capital |
45
![]() |
45
|
49 |
Employees (average) |
8
![]() |
8
|
10 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
3.6%
|
5.5%
|
10.3% |
Turnover per employee |
117
|
168
|
150 |
Profit as a percentage of turnover |
-19.5%
|
-3.6%
|
0% |
Return on assets (ROA) |
-9.5%
|
-2.8%
|
0.8% |
Current ratio |
88.9%
|
48.6%
|
57.6% |
Return on equity (ROE) |
-310.2%
|
-72.7%
|
0% |
Change turnover |
-410
|
-32
|
266 |
Change turnover % |
-30%
|
-2%
|
22% |
Chg. No. of employees |
0
|
-2
|
0 |
Chg. No. of employees % |
0%
|
-20%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.